| アブストラクト | OBJECTIVE: Estimate the prevalence of diagnosed Alzheimer's disease (AD) and early Alzheimer's disease (eAD) overall and stratified by age, sex and deprivation and combinations thereof in England on 1 January 2020. DESIGN: Cross-sectional. SETTING: Primary care electronic health record data, the Clinical Practice Research database linked with secondary care data, Hospital Episode Statistics (HES) and patient-level deprivation data, Index of Multiple Deprivation (IMD). OUTCOME MEASURES: The prevalence per 100 000 of the population and corresponding 95% CIs for both diagnosed AD and eAD overall and stratified by covariates. Sensitivity analyses were conducted to assess the sensitivity of the population definition and look-back period. RESULTS: There were 448 797 patients identified in the Clinical Practice Research Datalink that satisfied the study inclusion criteria and were eligible for HES and IMD linkage. For the main analysis of AD and eAD, 379 763 patients are eligible for inclusion in the denominator. This resulted in an estimated prevalence of diagnosed AD of 378.39 (95% CI, 359.36 to 398.44) per 100 000 and eAD of 292.81 (95% CI, 276.12 to 310.52) per 100 000. Prevalence estimates across main and sensitivity analyses for the entire AD study population were found to vary widely with estimates ranging from 137.48 (95% CI, 127.05 to 148.76) to 796.55 (95% CI, 768.77 to 825.33). There was significant variation in prevalence of diagnosed eAD when assessing the sensitivity with the look-back periods, as low as 120.54 (95% CI, 110.80 to 131.14) per 100 000, and as high as 519.01 (95% CI, 496.64 to 542.37) per 100 000. CONCLUSIONS: The study found relatively consistent patterns of prevalence across both AD and eAD populations. Generally, the prevalence of diagnosed AD increased with age and increased with deprivation for each age category. Women had a higher prevalence than men. More granular levels of stratification reduced patient numbers and increased the uncertainty of point prevalence estimates. Despite this, the study found a relationship between deprivation and prevalence of AD. |
|---|
| ジャーナル名 | BMJ open |
|---|
| Pubmed追加日 | 2023/10/26 |
|---|
| 投稿者 | Leahy, Thomas Patrick; Simpson, Alex; Sammon, Cormac; Ballard, Clive; Gsteiger, Sandro |
|---|
| 組織名 | Putnam LLC, Toronto, Ontario, Canada.;Global Access, F Hoffmann-La Roche AG, Basel, Switzerland.;Putnam LLC, Westport, Ireland.;University of Exeter Medical School, Exeter, UK.;Global Access, F Hoffmann-La Roche AG, Basel, Switzerland;sandro.gsteiger@roche.com. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/37879685/ |
|---|
